Literature DB >> 7292911

Tumours involving the brachial plexus in seven dogs.

S Carmichael, I R Griffiths.   

Abstract

Seven cases with tumours localised in the brachial plexus are described. The main clinical features were a progressive lameness in one forelimb with marked muscle atrophy and very obvious but non-localizable pain. A palpable lump in the axilla was present in less than half the cases. Ancillary aids contributed little in the diagnosis except for electrophysiology which gave evidence of neural damage at an early stage of the disease and as such may be the most useful aid to an early diagnosis. Two different pathological entities were observed, the first where the tumour, primarily of neural origin (usually a neurofibrosarcoma), arose within the nerves themselves and the second where the tumours arose in adjacent tissue and involved the plexus by local infiltration. In all cases the prognosis was hopeless because of local infiltration of the tumour and metastases. In the early stages accurate diagnosis can be difficult in the absence of a mass but the possibility should be considered in any case where chronic lameness with obvious non-localizable pain is present in one forelimb.

Entities:  

Mesh:

Year:  1981        PMID: 7292911     DOI: 10.1136/vr.108.20.435

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  2 in total

1.  Ultrasound-guided fine needle aspiration in the diagnosis of peripheral nerve sheath tumors in 4 dogs.

Authors:  Ronaldo C da Costa; Joane M Parent; Howard Dobson; Kristiina Ruotsalo; David Holmberg; M Carolina Duque; Roberto Poma
Journal:  Can Vet J       Date:  2008-01       Impact factor: 1.008

2.  Frameless stereotactic volumetric modulated arc radiotherapy of brachial plexus tumours in dogs: 10 cases.

Authors:  Mario Dolera; Luca Malfassi; Cristina Bianchi; Nancy Carrara; Sara Finesso; Silvia Marcarini; Giovanni Mazza; Simone Pavesi; Massimo Sala; Gaetano Urso
Journal:  Br J Radiol       Date:  2016-11-25       Impact factor: 3.039

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.